제10회 서울국제신약포럼 > Forum & Conference

본문 바로가기

파이낸셜뉴스 부산파이낸셜뉴스 fn투어 fn아이포커스 fn아트


지난행사목록

본문

 

 

 

Introduction  

 

 

The Seoul International New Pharmaceuticals Forum, which took its first step in 2009, celebrates 

its 10th anniversary this year.

  

The Seoul International New Pharmaceuticals Forum, which has been launched under the theme 

of "Beyond the Barrier of the Global New Pharmaceuticals" at the first Forum, has been dealing the 

major issues emerging in the development of new pharmaceuticals every year, such as △ Changes 

and challenges in the new pharmaceuticals development paradigm △ A new 10-year for 

Pharmaceutical and Bio fields △ Global innovative new pharmaceuticals - Customized medicines 

△ Creative economy era and R & D for new pharmaceuticals △ Creative paradigm of pharmaceutical 

industry: Establishment of a virtuous cycle structure for the development of new pharmaceuticals 

△ Research of new diseases due to bacteria and virus, development of therapeutic medicines and 

vaccines to control them △ Pharmaceutical industry, prior occupation of new market for therapeutic 

medicines to control rare diseases as a new growth engine and △ Development of new pharmaceuticals 

using medical big data.

  

In the meantime, the pharmaceutical industry has undergone drastic changes. In particular, domestic 

pharmaceutical companies have been making continuous efforts to develop new pharmaceuticals. 

As a result, exports of complete products of  pharmaceuticals surpassed $ 2 billion for the first time 

last year. This was achieved in four years after the export volume exceeded $ 1 billion in 2013. In 

addition, the exports of bio-pharmaceuticals, which have just entered the market, recorded over 

$1 billion in 2016.

  

Of course, there was a sharp decline in sales in 2010 due to the implementation of the bilateral 

punishment against rebate payment. However, large domestic pharmaceutical companies, including 

Hanmi Pharm. Company, have concluded contracts for technology exportation with global Big-Pharma. 

companies one after another, enhancing the possibility of new pharmaceutical development.

  

In response to this trend,  the Government, at the Pharmaceutical Industry Promotion Committee 

early this year, has disclosed that it will provide the implementation plan for detailed projects for the 

development of new pharmaceuticals using information and communication technology (ICT) and 

the development of next-generation bio-pharmaceuticals such as the medicines for l dementia and 

gene therapy in order take lead in the 4th industrial revolution.

  

At the Seoul International New Pharmaceuticals Forum this year, you can find out how Open 

Innovation, a  new conception emerging at the backdrop of the 4th industrial revolution, shall be 

applied to the development of new pharmaceuticals. Currently, there are cases where the results 

have reached clinical level through the inter-country projects with Duke University and University 

of Singapore.

  

In addition, IBM will present a review on how you can use AI, the core technology of the 4th industrial 

revolution, in  R & D for new pharmaceuticals development. Further, you will be furnished with 

updated information about CAR-T of Novartis, the personally customized cell therapy medicine, 

that has emerged as a new issue recently, as well as  AstraZeneca's 5R framework aimed to improve 

the productivity of new pharmaceuticals development researches.

  

The 10th Seoul International New Pharmaceuticals Forum will have the opportunity to examine 

how new technologies developing in the path of 4th industrial revolution, can help develop new 

pharmaceuticals through its application to such development projects.

 

 

 

Overview 

 

 

Title : The 10h Seoul International New Pharmaceuticals Forum

  

Theme : New Drug Development, Convergence with New Technology

 

Date : June 21st, 2018(Thu) / 09:00 ~ 16:00

 

Venue : Grand Ballroom, The Westin Chosun Hotel, Seoul

 

Host : The Financial News, Korea Research Institute of Chemical Technology

 

Supporters : Ministry of Health and Welfare, Ministry of Science and ICT, 

                        National Institute of Food and Drug Safety Evaluation,

                        Korea Pharmaceutical and Bio-Pharma Manufacturers Association, 

                        Korea Biotechnology Industry Organization,

                        Korea Research-based Pharmaceutical Industry Association


Inquiry : Seoul International New Pharmaceuticals Forum

                Tel. 02-6965-0014 / Mail. iamkhs@fnnews.com

서울특별시 용산구 효창원로 154, 파이낸셜뉴스빌딩 3층 | TEL. 02-6965-0016 | FAX. 02-6965-0000 | E-mail : info@fnnews.com
Copyright 2017 The financial news. All rights reserved.